Abstract: The invention provides dry compositions which when dissolved in water exhibit unexpectedly high antibacterial activity. The compositions comprise at least two of the following ingredients (a) to (d): (a) ascorbic acid and/or its salts (b) malic acid and/or tartaric acid and/or their salts (c) sodium saccharin and/or calcium saccharin (d) sodium benzoate and/or benzoic acid.
Type:
Grant
Filed:
September 22, 1989
Date of Patent:
February 26, 1991
Assignee:
Cadbury Schweppes Proprietary Limited
Inventors:
Michael Gracey, Frank Hopkins, Jennifer Robinson, Stephen Snow
Abstract: This invention provides trans-3,4 1-substituted-3-substituted-4-methyl-4-(3-substituted phenyl)piperidines as opioid antagonists capable of blocking the mu or kappa receptors in the brain.
Type:
Grant
Filed:
December 14, 1988
Date of Patent:
January 2, 1990
Assignees:
Kabushiki Kaisha Kobe Seikosho, Japan LSI Co., Ltd.
Abstract: A clear gel and a cream pharmaceutical composition containing meclofenamic acid are disclosed. The clear gel composition is prepared by dissolving meclofenamic acid in polyethylene glycol monolaurate and polyethylene glycol lanolin oil and adding isopropyl alcohol with mixing and finally adding colloidal silicon dioxide with mixing. The cream composition is prepared by adding meclofenamic acid or the sodium salt thereof to an emulsion prepared by mixing a warm aqueous solution of sorbic acid with a melt of polyethylene glycol monostearate, glyceryl monostearate, caprylic and capric triglyceride and mineral oil.The resulting compositions are indicated for the treatment of inflammation.
Abstract: 2-(4-aminobutoxy)stilbenes are prepared and found useful as pharmaceutical agents, particularly as anticonvulsants and skeletal muscle relaxants.
Abstract: The present invention relates to a novel synergistic composition and to a method of treating inflammation in warm blooded animals by topically administering to a warm blooded animal in need of such treatment an effective amount of the synergistic combination of a non-steroidal agent having anti-inflammatory activity and bis-(2-pyridyl-1-oxide) disulfide and/or at least one adduct of bis-(2-pyridyl-1-oxide) disulfide having the empirical formula:(C.sub.5 H.sub.4 NOS).sub.2 MY.sub.t (I)wherein M represents a member selected from the group consisting of zinc, iron, magnesium, tin, cadmium, zirconium, alkali and alkaline earth metals; Y is the anion of an inorganic acid and t is either 1 or 2.
Abstract: A method for treating Central Nervous System depression and anxiety in a mammal by administering internally to the mammal an effective psychoactive amount of a phenylazoimidazole compound.
Type:
Grant
Filed:
May 6, 1977
Date of Patent:
March 14, 1978
Assignee:
The Dow Chemical Company
Inventors:
Abdulmuniem H. Abdallah, Philip J. Shea
Abstract: There is described a pharmaceutical mixture comprising 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol, or a pharmaceutically acceptable salt thereof, and aspirin or indomethacin. The mixture causes less gastrointestinal adverse effects than aspirin or indomethacin on their own.
Type:
Grant
Filed:
November 18, 1976
Date of Patent:
January 3, 1978
Assignee:
Fisons Limited
Inventors:
Thomas Samuel Campbell Orr, David Edward Hall, John Mann
Abstract: New propiophenone derivatives prepared by the reaction of propiophenone, formaldehyde and piperidine, as well as pharmacologically acceptable acid-addition salts thereof are provided, which possess improved pharmacological activities such as anti-tremorine and anti-nicotine activities superior to those of the known analogous compound. The new compounds are useful for the therapeutic treatment of human patient suffering from pathological muscular contracture, spastic paralysis due to cerebral apoplexy, spinal and cerebral palsies and the like.